Order Article Reprints

Siddique MH, Bukhari S, Khan IU, Essa A, Ali Z, Sabir U, Ayoub O, Saadia H, Yaseen M, Sultan A, et al. In Silico, In Vitro, and In Vivo Evaluation of Caffeine-Coated Nanoparticles as a Promising Therapeutic Avenue for AML through NF-Kappa B and TRAIL Pathways Modulation. Pharmaceuticals. 2023; 16(12):1742. https://doi.org/10.3390/ph16121742

Siddique, Muhammad Hamid, Sidra Bukhari, Inam Ullah Khan, Asiya Essa, Zain Ali, Usama Sabir, Omiya Ayoub, Haleema Saadia, Muhammad Yaseen, Aneesa Sultan, and et al. 2023. "In Silico, In Vitro, and In Vivo Evaluation of Caffeine-Coated Nanoparticles as a Promising Therapeutic Avenue for AML through NF-Kappa B and TRAIL Pathways Modulation" Pharmaceuticals 16, no. 12: 1742. https://doi.org/10.3390/ph16121742

Siddique, M. H., Bukhari, S., Khan, I. U., Essa, A., Ali, Z., Sabir, U., Ayoub, O., Saadia, H., Yaseen, M., Sultan, A., Murtaza, I., Kerr, P. G., Bhat, M. A., & Anees, M. (2023). In Silico, In Vitro, and In Vivo Evaluation of Caffeine-Coated Nanoparticles as a Promising Therapeutic Avenue for AML through NF-Kappa B and TRAIL Pathways Modulation. Pharmaceuticals, 16(12), 1742. https://doi.org/10.3390/ph16121742